{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:34Z","timestamp":1792785934452,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"European Crohn\u2019s and Colitis Organization, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, and Takeda","award":["CW2522671"],"award-info":[{"award-number":["CW2522671"]}],"id":[{"id":"https:\/\/ror.org\/05beaae04","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["426160"],"award-info":[{"award-number":["426160"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and aim<\/jats:title>\n                    <jats:p>Metabolites produced through host-microbe interactions may help associate metabolomic signatures with therapy response. We aimed to assess serum metabolites as predictors of vedolizumab remission in children with IBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>VedoKids was a multicenter, prospective cohort study of children initiating vedolizumab at any stage of disease. Serum metabolomic profiling was performed at baseline (W0), week 14 (W14), and week 30 (W30) using quantitative metabolomics based on DI\/LC-MS\/MS method. Random Forest (RF) models with maximum relevance\u2013minimum redundancy (mRMR) feature selection, integrated clinical and metabolomic features to predict clinical remission at the next time point (ie, week 0 to week 14; week 14 to week 30; week 30 to week 54).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One hundred thirty-eight patients were included (mean age 13.6\u2009years), 64 with Crohn disease (CD) and 74 with ulcerative colitis (UC). In CD, models achieved an area under the receiver operating characteristic curve (AUROC) of 0.80 (95% CI, 0.68-0.92) for predicting response to vedolizumab at W14, 0.92 (95% CI, 0.85-0.99) at W30 , and 0.83 (95% CI, 0.72-0.94) at W54. Metabolites appeared among the most important features, notably PC ae C36:4, citric acid, and malic acid. In UC, corresponding AUROC were 0.72 (95% CI, 0.59-0.85) at W14, 0.77 (95% CI, 0.64-0.90) at W30, and 0.90 (95% CI, 0.80-1.00) at W54. LysoPC a C26:1, picolinic acid, and serotonin were among the most important metabolites for prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified serum metabolites associated with vedolizumab remission in children with IBD, several of which have been previously linked to IBD pathophysiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag154","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:40:27Z","timestamp":1784374827000},"page":"1880-1887","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics predict treatment response to vedolizumab in pediatric IBD: results from the prospective VedoKids cohort study"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-7894","authenticated-orcid":false,"given":"Ricardo G","family":"Suarez","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Alberta , Edmonton AB, T6G 1C9,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Bar Or","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alberta , Edmonton AB, T6G 1C9,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Orlanski-Meyer","sequence":"additional","affiliation":[{"name":"Shaare Zedek Medical Center Institute of Pediatric Gastroenterology and Nutrition, , P.O. Box 3235 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivia","family":"Shavit","sequence":"additional","affiliation":[{"name":"Shaare Zedek Medical Center Institute of Pediatric Gastroenterology and Nutrition, , P.O. Box 3235 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4952-3729","authenticated-orcid":false,"given":"Asaf","family":"Azulay","sequence":"additional","affiliation":[{"name":"Shaare Zedek Medical Center Institute of Pediatric Gastroenterology and Nutrition, , P.O. Box 3235 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Broide","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology Hepatology and Nutrition Unit, Assaf Harofeh Medical Center , Zerifin 703301,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-538X","authenticated-orcid":false,"given":"Darja","family":"Urlep","sequence":"additional","affiliation":[{"name":"University Children\u2019s Hospital Pediatric Gastroenterology and Liver Unit, ,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Art","family":"Kastl","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia Division of Gastroenterology, Hepatology and Nutrition, , Philadelphia, PA 19104,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Hyams","sequence":"additional","affiliation":[{"name":"Connecticut Children\u2019s Medical Center , Hartford, CT,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Levine","sequence":"additional","affiliation":[{"name":"NYU Langone Health Pediatric Gastroenterology, , 06106,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Rosh","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Hepatology and Nutrition, Atlantic Health System\/Atlantic Children\u2019s Health , Morristown, NJ 07601,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology and Nutrition, Royal Hospital for Children and Young People , Edinburgh EH16 4TJ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5160-868X","authenticated-orcid":false,"given":"Dan","family":"Turner","sequence":"additional","affiliation":[{"name":"Shaare Zedek Medical Center Institute of Pediatric Gastroenterology and Nutrition, , P.O. Box 3235 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-4142","authenticated-orcid":false,"given":"Eytan","family":"Wine","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alberta , Edmonton AB, T6G 1C9,","place":["Canada"]},{"name":"Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children, and University of Toronto , Toronto, ON M5G 1X8,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026093014385698100_izag154-B1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"2026093014385698100_izag154-B2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2008.06.079","article-title":"Natural history of pediatric Crohn\u2019s disease: a population-based cohort study","volume":"135","author":"Vernier-Massouille","year":"2008","journal-title":"Gastroenterology"},{"key":"2026093014385698100_izag154-B3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ibd.21145","article-title":"Inflammatory bowel disease in young people","volume":"16","author":"Goodhand","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2026093014385698100_izag154-B4","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1080\/21645515.2019.1591139","article-title":"A product review of vedolizumab in inflammatory bowel disease","volume":"15","author":"Battat","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2026093014385698100_izag154-B5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cgh.2019.04.012","article-title":"Development and validation of the mucosal inflammation noninvasive index for pediatric Crohn\u2019s disease","volume":"18","author":"Cozijnsen","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026093014385698100_izag154-B6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S2468-1253(24)00319-4","article-title":"Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study","volume":"10","author":"Atia","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026093014385698100_izag154-B7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S2468-1253(22)00307-7","article-title":"Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study","volume":"8","author":"Atia","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026093014385698100_izag154-B8","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/ph14111190","article-title":"Metabolomics insights into inflammatory bowel disease: a comprehensive review","volume":"14","author":"Aldars-Garc\u00eda","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2026093014385698100_izag154-B9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4049\/jimmunol.1601247","article-title":"Microbiome-modulated metabolites at the interface of host immunity","volume":"198","author":"Blacher","year":"2017","journal-title":"J Immunol"},{"key":"2026093014385698100_izag154-B10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/ecco-jcc\/jjw158","article-title":"Faecal and serum metabolomics in paediatric inflammatory bowel disease","volume":"11","author":"Kolho","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2026093014385698100_izag154-B11","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.3748\/wjg.v20.i12.3231","article-title":"Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies","volume":"20","author":"Bennike","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026093014385698100_izag154-B12","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1021\/acs.jafc.9b00204","article-title":"Chemical composition of commercial cow\u2019s milk","volume":"67","author":"Foroutan","year":"2019","journal-title":"J Agric Food Chem"},{"key":"2026093014385698100_izag154-B13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/metabo10060233","article-title":"The bovine metabolome","volume":"10","author":"Foroutan","year":"2020","journal-title":"Metabolites"},{"key":"2026093014385698100_izag154-B14","doi-asserted-by":"crossref","first-page":"117298","DOI":"10.1016\/j.eswa.2022.117298","article-title":"A bi-objective K-nearest-neighbors-based imputation method for multilevel data","volume":"204","author":"Cubillos","year":"2022","journal-title":"Expert Syst Appl"},{"key":"2026093014385698100_izag154-B15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1142\/s0219720005001004","article-title":"Minimum redundancy feature selection from microarray gene expression data","volume":"3","author":"Ding","year":"2005","journal-title":"J Bioinform Comput Biol"},{"key":"2026093014385698100_izag154-B16","first-page":"1833","article-title":"Permutation tests for studying classifier performance","volume":"11","author":"Ojala","year":"2010","journal-title":"J Mach Learn Res"},{"key":"2026093014385698100_izag154-B17","doi-asserted-by":"publisher","first-page":"113653","DOI":"10.1016\/j.intimp.2024.113653","article-title":"The malic acid inhibiting inflammation in ankylosing spondylitis by interfering M1 macrophage polarization","volume":"144","author":"Ji","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"2026093014385698100_izag154-B18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/antiox13020253","article-title":"Maternal malic acid may ameliorate oxidative stress and inflammation in sows through modulating gut microbiota and host metabolic profiles during late pregnancy","volume":"13","author":"Chen","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"2026093014385698100_izag154-B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40104-025-01163-3","article-title":"Malic enzyme 3 mediated the effects of malic acid on intestinal redox status and feed efficiency in broilers","volume":"16","author":"Jiang","year":"2025","journal-title":"J Anim Sci Biotechnol"},{"key":"2026093014385698100_izag154-B20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/ijms25021239","article-title":"Citric acid promotes immune function by modulating the intestinal barrier","volume":"25","author":"Hu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026093014385698100_izag154-B21","doi-asserted-by":"publisher","first-page":"751861","DOI":"10.3389\/fvets.2021.751861","article-title":"Citric acid promoting B lymphocyte differentiation and anti-epithelial cells apoptosis mediate the protective effects of Hermetia illucens feed in ETEC induced piglets diarrhea","volume":"8","author":"Liu","year":"2021","journal-title":"Front Vet Sci"},{"key":"2026093014385698100_izag154-B22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.toxrep.2018.08.002","article-title":"Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: a series of four case reports","volume":"5","author":"Sweis","year":"2018","journal-title":"Toxicol Rep"},{"key":"2026093014385698100_izag154-B23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1080\/14786419.2019.1601196","article-title":"Citrus fruits and their flavonoids in inflammatory bowel disease: an overview","volume":"34","author":"Musumeci","year":"2020","journal-title":"Nat Prod Res"},{"key":"2026093014385698100_izag154-B24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/ecco-jcc\/jjv231","article-title":"Dimethyl fumarate reduces inflammatory responses in experimental colitis","volume":"10","author":"Casili","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2026093014385698100_izag154-B25","doi-asserted-by":"publisher","first-page":"11949","DOI":"10.1021\/acs.jmedchem.2c00390","article-title":"Discovery of novel imidazo[4,5- c] quinoline derivatives to treat inflammatory bowel disease (IBD) by inhibiting multiple proinflammatory signaling pathways and restoring intestinal homeostasis","volume":"65","author":"Liang","year":"2022","journal-title":"J Med Chem"},{"key":"2026093014385698100_izag154-B26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/genes14061257","article-title":"Possible effects of uremic toxins p-cresol, indoxyl sulfate, p-cresyl sulfate on the development and progression of colon cancer in patients with chronic renal failure","volume":"14","author":"Di Paola","year":"2023","journal-title":"Genes (Basel)"},{"key":"2026093014385698100_izag154-B27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/00365520410006233","article-title":"Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray-tandem mass spectrometry","volume":"39","author":"Ehehalt","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"2026093014385698100_izag154-B28","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1002\/ibd.20993","article-title":"Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis","volume":"15","author":"Braun","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"2026093014385698100_izag154-B29","doi-asserted-by":"publisher","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci"},{"key":"2026093014385698100_izag154-B30","doi-asserted-by":"publisher","first-page":"adv00407","DOI":"10.2340\/00015555-3766","article-title":"Metabolomic analysis of skin biopsies from patients with atopic dermatitis reveals hallmarks of inflammation, disrupted barrier function and oxidative stress","volume":"101","author":"Ilves","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"2026093014385698100_izag154-B31","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.3390\/ijms20143564","article-title":"Alteration of sphingolipids in biofluids: implications for neurodegenerative diseases","volume":"20","author":"Pujol-Lereis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026093014385698100_izag154-B32","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.3390\/nu15204466","article-title":"Roles of short-chain fatty acids in inflammatory bowel disease","volume":"15","author":"Shin","year":"2023","journal-title":"Nutrients"},{"key":"2026093014385698100_izag154-B33","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/ibd\/izy103","article-title":"Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis","volume":"24","author":"Sofia","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026093014385698100_izag154-B34","first-page":"259","article-title":"The role of 5-HT dysregulation in inflammatory bowel disease","volume":"9","author":"Khan","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2026093014385698100_izag154-B35","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.cgh.2018.11.012","article-title":"Serum concentrations of 7\u03b1-hydroxy-4-cholesten-3-one are associated with bile acid diarrhea in patients with Crohn\u2019s disease","volume":"17","author":"Battat","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/10\/1880\/70531314\/izag154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/10\/1880\/70531314\/izag154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:39:03Z","timestamp":1790793543000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/10\/1880\/8754139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag154","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,7]]}}}